Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]

DUBLIN--()--Regulatory News:

1   Details of the person discharging managerial responsibilities/person closely associated
a) Name  

Mr. Jason Hannon

 

2 Reason for the notification
a) Position/status

Director

b) Initial Notification Amendment


Initial Notification

3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name

Mainstay Medical International plc (the “Company”)

b) LEI 635400IUPSOZ26H56Y03
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument,

type of

instrument

Identification code

Share options over Company Ordinary Shares

 

 

 

ISIN IE00BJYS1G50

b) Nature of the transaction Grant of share options over Company Ordinary Shares to Mr. Hannon pursuant to the Company’s 2014 Share Option Plan.
c) Price(s) and volume(s)

Price(s)

The exercise price relating to the share options is €14.85 in accordance with the Company’s 2014 Share Option Plan

 

 

Volume(s)

401,862

d) Aggregated information

— Aggregated volume

— Price

 

Not Applicable

e) Date of the transaction

9 October 2017

f) Place of the transaction

Not Applicable

g) Additional Information

 

None

Contacts

FTI Consulting for Mainstay Medical International plc
Jonathan Neilan
+353-1-663-3686
Jonathan.Neilan@fticonsulting.com

Contacts

FTI Consulting for Mainstay Medical International plc
Jonathan Neilan
+353-1-663-3686
Jonathan.Neilan@fticonsulting.com